Human Genome Epidemiology Literature Finder
|
Records 1 - 4 (of 4 Records) |
| Query Trace: Wilms Tumor and EFS[original query] |
|---|
| WT1 overexpression at diagnosis may predict favorable outcome in patients with de novo non-M3 acute myeloid leukemia. Leukemia & lymphoma 2011 Oct 52 (10): 1961-9. Miglino Maurizio, Colombo Nicoletta, Pica Gianmatteo, Grasso Raffaella, Clavio Marino, Bergamaschi Micaela, Ballerini Filippo, Ghiso Anna, Ghiggi Chiara, Mitscheunig Laura, Beltrami Germana, Cagnetta Antonia, Vignolo Luana, Lucchetti Maria Vita, Aquino Sara, Pierri Ivana, Sessarego Mario, Carella Angelo Michele, Gobbi Mar |
| Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2012 Jan . Renneville A, Boissel N, Nibourel O, Berthon C, Helevaut N, Gardin C, Cayuela JM, Hayette S, Reman O, Contentin N, Bordessoule D, Pautas C, Botton SD, Revel TD, Terre C, Fenaux P, Thomas X, Castaigne S, Dombret H, Preudhomme C |
| WT1 mutations are secondary events in AML, show varying frequencies and impact on prognosis between genetic subgroups. Leukemia 2015 Mar 29 (3): 660-7. Krauth M-T, Alpermann T, Bacher U, Eder C, Dicker F, Ulke M, Kuznia S, Nadarajah N, Kern W, Haferlach C, Haferlach T, Schnittger |
| Wilms tumor gene single nucleotide polymorphism rs16754 predicts a favorable outcome in children with acute lymphoblastic leukemia. Journal of cancer research and clinical oncology 2015 Jul . Junghanns Anne-Sophie, Wittig Susan, Woehlecke Caroline, Lehmann Thomas, Arndt Clemens, Gruhn Ber |
- Page last reviewed:Feb 1, 2024
- Content source: